# Magellan Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/magellan-biosciences

- Industry: Medical Devices & Equipment
- Headquarters: Chelmsford, US
- Website: www.magellanbio.com
- Total disclosed funding: $50M
- Latest round: Series A (Nov 28, 2006)
- Investors on record: 7

## About

Based in MA, US, Magellan serves the worldwide clinical-diagnostics market with rapid point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.

## Funding rounds

- Series A, Nov 28, 2006, $50M — Abingworth, Ampersand, KBL Healthcare Ventures, BlueHub Capital, Tekla Capital Management, NMT Capital, New England Partners Capital

## Investors

- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A
- Ampersand (https://capitalatlas.ai/funds/ampersand) — Series A
- KBL Healthcare Ventures (https://capitalatlas.ai/funds/kbl-healthcare-ventures) — Series A
- BlueHub Capital (https://capitalatlas.ai/funds/bluehub-capital) — Series A
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series A
- NMT Capital (https://capitalatlas.ai/funds/nmt-capital) — Series A
- New England Partners Capital — Series A